35Pharma is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need.
35Pharma has raised $53.0M in total funding. The most recent round was Series C. The last funding was announced in November 2024.
35Pharma's investors include Vivo Capital, Janus Henderson Investors, Frazier Life Sciences, Columbia Threadneedle Investments, Deep Track Capital.
35Pharma is headquartered in Montreal, Canada.
35Pharma is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need.
35Pharma is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"35Pharma — Funding & Investors." VCBacked, November 26, 2024, https://www.vcbacked.co/company/35pharma. Accessed July 19, 2026.
VCBacked. (2024). 35Pharma — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/35pharma
{{cite web |title=35Pharma — Funding & Investors |url=https://www.vcbacked.co/company/35pharma |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated